4-(2-Azidoethoxy)-3-methoxy-benzylamine Trifluoroacetate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2-Azidoethoxy)-3-methoxy-benzylamine Trifluoroacetate
• 英文别名: [4-(2-azidoethoxy)-3-methoxyphenyl]methanamine;2,2,2-trifluoroacetic acid
• 化学式: C₂HF₃O₂*C₁₀H₁₄N₄O₂
• 分子量: 336.271
• InChiKey: PXXNYPLIPQKCJG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.48
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  96.1
• 氢给体数：
  2
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  4-(2-Azidoethoxy)-3-methoxy-benzylamine Trifluoroacetate 在 三乙胺 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 生成 2,2-Dimethyl Propionic Acid 2-{3-[4-(2-Azidoethoxy)-3-methoxybenzyl]thioureido Methyl}-3-(3,4-dimethylphenyl)propyl ester
  参考文献：
  名称：

  Phenolic Modification as an Approach to Improve the Pharmacology of the 3-Acyloxy-2-benzylpropyl Homovanillic Amides and Thioureas, a Promising Class of Vanilloid Receptor Agonists and Analgesics

  摘要：

  In order to improve the analgesic activity and pharmacokinetics of thioureas 2 and 3, which we previously developed as potent vanilloid receptor (VR) agonists, we prepared and characterized phenolic modifications of them and of their amide surrogates (7, 8). The aminoethyl analogue of the amide template 13 was a potent analgesic with an EC50 = 0.96 mug/kg in the AA-induced writhing test and with better in vivo stability than the parent phenol. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00387-x
• 作为产物：
  描述：

  香兰素胺盐酸盐 在 氢氧化钾 、 sodium azide 、 四丁基氢氧化铵 、 三乙胺 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 35.0h， 生成 4-(2-Azidoethoxy)-3-methoxy-benzylamine Trifluoroacetate
  参考文献：
  名称：

  Phenolic Modification as an Approach to Improve the Pharmacology of the 3-Acyloxy-2-benzylpropyl Homovanillic Amides and Thioureas, a Promising Class of Vanilloid Receptor Agonists and Analgesics

  摘要：

  In order to improve the analgesic activity and pharmacokinetics of thioureas 2 and 3, which we previously developed as potent vanilloid receptor (VR) agonists, we prepared and characterized phenolic modifications of them and of their amide surrogates (7, 8). The aminoethyl analogue of the amide template 13 was a potent analgesic with an EC50 = 0.96 mug/kg in the AA-induced writhing test and with better in vivo stability than the parent phenol. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00387-x

文献信息

• Vanilloid analogues containing resinferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
  申请人：Pacific Corporation

  公开号：US06476076B1

  公开（公告）日：2002-11-05

  The present invention is related to new vanilloid analogues containing resiniferatoxin pharmacophores, pharmaceutical compositions comprising such analogues, and their uses as vanilloid receptor agonists and potent analgesics. The present invention provides a pharmaceutical composition for treating acute, chronic, inflammatory or neuropathic pains or for treating bladder hypersensitivity.

  本发明涉及含有树脂花椒毒素药效团的新香草酸类似物，包括这种类似物的药物组合物，以及它们作为香草受体激动剂和强效止痛药的用途。本发明提供了一种用于治疗急性、慢性、炎症性或神经病性疼痛或治疗膀胱过敏的药物组合物。
• VANILLOID ANALOGUES CONTAINING RESINIFERATOXIN PHARMACOPHORES AS POTENT VANILLOID RECEPTOR AGONISTS AND ANALGESICS, COMPOSITIONS AND USES THEREOF
  申请人：PACIFIC CORPORATION

  公开号：EP1154989B1

  公开（公告）日：2005-12-14
• US6476076B1
  申请人：——

  公开号：US6476076B1

  公开（公告）日：2002-11-05
• [EN] VANILLOID ANALOGUES CONTAINING RESINIFERATOXIN PHARMACOPHORES AS POTENT VANILLOID RECEPTOR AGONISTS AND ANALGESICS, COMPOSITIONS AND USES THEREOF<br/>[FR] ANALOGUES DE VANILLOIDE CONTENANT DES PHARMACOPHORES DE RESINIFERATOXINE, UTILISES EN TANT QU'AGONISTES DU RECEPTEUR DE VANILLOIDE ET ANALGESIQUES PUISSANTS, COMPOSITIONS ET LEURS UTILISATIONS
  申请人：PACIFIC CORP

  公开号：WO2000050387A1

  公开（公告）日：2000-08-31

  The present invention is related to new vanilloid analogues containing resiniferatoxin pharmacophores, pharmaceutical compositions comprising such analogues, and their uses as vanilloid receptor agonists and potent analgesics. The present invention provides a pharmaceutical composition for treating acute, chronic, inflammatory or neuropathic pains or for treating bladder hypersensitivity.